Numerous genetic factors may contribute to the risk of ACC, including abnormalities in β-catenin, insulin-like growth factor (IGF)-II/IGF-IR, and p53/Rb signaling pathways. The gene discussed is IGF2; the disease is adrenal cortex carcinoma.